ATC Abstracts

American Transplant Congress abstracts

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions
View by Date

Saturday, April 29, 2017

5:30pm-7:30pm
Elevated Circulating AT1R Levels Indicate Heightened Risk for Antibody Mediated Rejection and Graft Failure.

P. Kimball, G. Gupta, F. McDougan.

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1
5:30pm-7:30pm
Emerging Variables Which May Enhance Care of HIV Positive Renal Transplant Recipients.

D. Leonard, M. Prendergast.

Poster Session A: Viral Conundrums  •  Hall D1
5:30pm-7:30pm
Enhanced Liver Regeneration After Partial Hepatectomy in Mice Treated with a Prolyl Hydroxylase Inhibitor.

J. Latona,1 A. Shah,1 J. Cheng,2 P. Messersmith,2 E. Heber-Katz.3

Poster Session A: Ischemic Injury and Organ Preservation Session I  •  Hall D1
5:30pm-7:30pm
Estimating Donor Organ Quality with Baseline Histology and Kidney Donor Risk Index for Predicting Graft Outcomes in Deceased Donor Kidney Transplantation.

K. Park,1 S. Park,2 H. Park,2 J. Park,1 H. Chung,1 M. Kim,3 H. Cho,2 J. Lee.1

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection  •  Hall D1
5:30pm-7:30pm
Evaluation of Immunological States of Patients with Cytomegalovirus Infection After Kidney Transplantation.

A. Tanaka, K. Ide, Y. Tanaka, K. Ishiyama, M. Ohira, H. Tahara, S. Shimizu, D. Kumar, H. Ohdan.

Poster Session A: Viral Conundrums  •  Hall D1
5:30pm-7:30pm
Expanded Criteria for HCC in Liver Transplantation.

M. Haberal,1 A. Akdur,1 G. Moray,1 G. Arslan,2 F. Ozcay,3 H. Selcuk,4 H. Ozdemir.5

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Hall D1
5:30pm-7:30pm
Facing Unintended Challenges of Increased Risk Donor Kidneys in a New Kidney Allocation Era.

A. Rahnemai-Azar,1 J. Perkins,1 A. Limaye,2 N. Leca,3 C. Blosser,3 C. Johnson,3 S. Morrison,1 R. Bakthavatsalam,1 L. Sibulesky.1

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection  •  Hall D1
5:30pm-7:30pm
Factors Affecting Desensitization Outcome.

A. Zachary,1 R. Montgomery,2 M. Leffell.1

Poster Session A: Clinical Science: Kidney Immunosuppression: Desensitization  •  Hall D1
5:30pm-7:30pm
Favorable Long-Term Prognosis of Hepatitis B Surface Antigen Positive Intrahepatic Cholangiocarcinoma for Both Hepatic Resection and Incidental Liver Transplantation via Inhibiting Cancer-Associated Lymphangiogenesis.

J. Gu, S. Jeong, M. Sha, J. Zhang, Q. Xia.

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Hall D1
5:30pm-7:30pm
Fibromuscular Dysplasia in Living Kidney Donors: Characteristics and Recipient Outcomes.

M. Gonzalez Suarez, H. Amer, I. Jaffer, T. Vrtiska, A. Rule, M. Prieto, S. Textor.

Poster Session A: Living Donor Kidney Transplant I  •  Hall D1